Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)

Md Rezwan Ahmed Mahedi; Anurag Rawat; Fazle Rabbi; K. Suresh Babu; Elias Salvador Tasayco; Franklin Ore Areche; Olga Vicentina Pacovilca-Alejo; Denis Dante Corilla Flores; Salomón Vivanco Aguilar; Fredmoore L. Orosco; Nikolaos Syrmos; Mustafa Mudhafar; Sadia Afrin; Mst Mahfuza Rahman

doi:10.52711/0974-360X.2023.00592

Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)

Md Rezwan Ahmed Mahedi
, Anurag Rawat
, Fazle Rabbi
, K. Suresh Babu
, Elias Salvador Tasayco
, Franklin Ore Areche
, Olga Vicentina Pacovilca-Alejo
, Denis Dante Corilla Flores
, Salomón Vivanco Aguilar
, Fredmoore L. Orosco
, Nikolaos Syrmos
, Mustafa Mudhafar
, Sadia Afrin
, Mst Mahfuza Rahman

Department of Pharmacy
Comilla University
Cardiology Himalayan Institute of Medical Science Jolly Grant Dehradun
Australian Computer Society Inc.
Department of Biochemistry
Symbiosis International University
Universidad Nacional San Luis Gonzaga de Ica
Universidad Nacional de Huancavelica
Industrial Technology Development Institute Philippines
Human Performance and Health
Aristotle University of Thessaloniki
Department of Pharmaceutical Chemistry
Ahl Al Bayt University

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

Nipah virus (NIV) infection was identified in 1998, in Malaysia. The virus belongs to the Paramyxoviridae family. In the past, the virus was spread in Bangladesh, India, as well as Singapore. It affects our nervous system and the respiratory system, which is highly dangerous for our lives. It is caused by an RNA virus and has a high mortality rate. This virus can be transmitted from bats to humans, pigs to humans, or humans to humans. It is conceptualized that fruit bats like Pteropus vampyrus and Pteropus hypomelanus are responsible for transmitting the virus. From 1999 to 2022, there is no approved vaccine and medicines for the treatment of nipah virus infection. The fatality rate of this nipah virus is 75% to 95%. Moreover, NiV B (Bangladesh) is more deathly than NiV M (Malaysia). In present, some vaccines are under trial on pigs, horses and the monkey. In this review we try to focus on the barrier of vaccine and medicine development for this nipah virus.

Original language	English
Pages (from-to)	3588-3594
Number of pages	7
Journal	Research Journal of Pharmacy and Technology
Volume	16
Issue number	8
DOIs	https://doi.org/10.52711/0974-360X.2023.00592
State	Published - Aug 2023

Keywords

Bangladesh, etc
Bats
Encephalitis
Molecular Epidemiology
Nipah virus (NIV)
Pathogenicity
Respiratory system

Access to Document

10.52711/0974-360X.2023.00592

Cite this

Mahedi, M. R. A., Rawat, A., Rabbi, F., Babu, K. S., Salvador Tasayco, E., Areche, F. O., Pacovilca-Alejo, O. V., Flores, D. D. C., Aguilar, S. V., Orosco, F. L., Syrmos, N., Mudhafar, M., Afrin, S., & Rahman, M. M. (2023). Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV). Research Journal of Pharmacy and Technology, 16(8), 3588-3594. https://doi.org/10.52711/0974-360X.2023.00592

@article{06b77fce367e4c48a32726fcdeb92c4d,

title = "Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)",

abstract = "Nipah virus (NIV) infection was identified in 1998, in Malaysia. The virus belongs to the Paramyxoviridae family. In the past, the virus was spread in Bangladesh, India, as well as Singapore. It affects our nervous system and the respiratory system, which is highly dangerous for our lives. It is caused by an RNA virus and has a high mortality rate. This virus can be transmitted from bats to humans, pigs to humans, or humans to humans. It is conceptualized that fruit bats like Pteropus vampyrus and Pteropus hypomelanus are responsible for transmitting the virus. From 1999 to 2022, there is no approved vaccine and medicines for the treatment of nipah virus infection. The fatality rate of this nipah virus is 75\% to 95\%. Moreover, NiV B (Bangladesh) is more deathly than NiV M (Malaysia). In present, some vaccines are under trial on pigs, horses and the monkey. In this review we try to focus on the barrier of vaccine and medicine development for this nipah virus.",

keywords = "Bangladesh, etc, Bats, Encephalitis, Molecular Epidemiology, Nipah virus (NIV), Pathogenicity, Respiratory system",

author = "Mahedi, \{Md Rezwan Ahmed\} and Anurag Rawat and Fazle Rabbi and Babu, \{K. Suresh\} and \{Salvador Tasayco\}, Elias and Areche, \{Franklin Ore\} and Pacovilca-Alejo, \{Olga Vicentina\} and Flores, \{Denis Dante Corilla\} and Aguilar, \{Salom{\'o}n Vivanco\} and Orosco, \{Fredmoore L.\} and Nikolaos Syrmos and Mustafa Mudhafar and Sadia Afrin and Rahman, \{Mst Mahfuza\}",

year = "2023",

month = aug,

doi = "10.52711/0974-360X.2023.00592",

language = "Ingl{\'e}s",

volume = "16",

pages = "3588--3594",

journal = "Research Journal of Pharmacy and Technology",

issn = "0974-3618",

publisher = "A and V Publication",

number = "8",

}

Mahedi, MRA, Rawat, A, Rabbi, F, Babu, KS, Salvador Tasayco, E, Areche, FO , Pacovilca-Alejo, OV , Flores, DDC, Aguilar, SV, Orosco, FL, Syrmos, N, Mudhafar, M, Afrin, S & Rahman, MM 2023, 'Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)', Research Journal of Pharmacy and Technology, vol. 16, no. 8, pp. 3588-3594. https://doi.org/10.52711/0974-360X.2023.00592

TY - JOUR

T1 - Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)

AU - Mahedi, Md Rezwan Ahmed

AU - Rawat, Anurag

AU - Rabbi, Fazle

AU - Babu, K. Suresh

AU - Salvador Tasayco, Elias

AU - Areche, Franklin Ore

AU - Pacovilca-Alejo, Olga Vicentina

AU - Flores, Denis Dante Corilla

AU - Aguilar, Salomón Vivanco

AU - Orosco, Fredmoore L.

AU - Syrmos, Nikolaos

AU - Mudhafar, Mustafa

AU - Afrin, Sadia

AU - Rahman, Mst Mahfuza

PY - 2023/8

Y1 - 2023/8

N2 - Nipah virus (NIV) infection was identified in 1998, in Malaysia. The virus belongs to the Paramyxoviridae family. In the past, the virus was spread in Bangladesh, India, as well as Singapore. It affects our nervous system and the respiratory system, which is highly dangerous for our lives. It is caused by an RNA virus and has a high mortality rate. This virus can be transmitted from bats to humans, pigs to humans, or humans to humans. It is conceptualized that fruit bats like Pteropus vampyrus and Pteropus hypomelanus are responsible for transmitting the virus. From 1999 to 2022, there is no approved vaccine and medicines for the treatment of nipah virus infection. The fatality rate of this nipah virus is 75% to 95%. Moreover, NiV B (Bangladesh) is more deathly than NiV M (Malaysia). In present, some vaccines are under trial on pigs, horses and the monkey. In this review we try to focus on the barrier of vaccine and medicine development for this nipah virus.

AB - Nipah virus (NIV) infection was identified in 1998, in Malaysia. The virus belongs to the Paramyxoviridae family. In the past, the virus was spread in Bangladesh, India, as well as Singapore. It affects our nervous system and the respiratory system, which is highly dangerous for our lives. It is caused by an RNA virus and has a high mortality rate. This virus can be transmitted from bats to humans, pigs to humans, or humans to humans. It is conceptualized that fruit bats like Pteropus vampyrus and Pteropus hypomelanus are responsible for transmitting the virus. From 1999 to 2022, there is no approved vaccine and medicines for the treatment of nipah virus infection. The fatality rate of this nipah virus is 75% to 95%. Moreover, NiV B (Bangladesh) is more deathly than NiV M (Malaysia). In present, some vaccines are under trial on pigs, horses and the monkey. In this review we try to focus on the barrier of vaccine and medicine development for this nipah virus.

KW - Bangladesh, etc

KW - Bats

KW - Encephalitis

KW - Molecular Epidemiology

KW - Nipah virus (NIV)

KW - Pathogenicity

KW - Respiratory system

UR - https://www.scopus.com/pages/publications/85178963706

U2 - 10.52711/0974-360X.2023.00592

DO - 10.52711/0974-360X.2023.00592

M3 - Artículo

AN - SCOPUS:85178963706

SN - 0974-3618

VL - 16

SP - 3588

EP - 3594

JO - Research Journal of Pharmacy and Technology

JF - Research Journal of Pharmacy and Technology

IS - 8

ER -

Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this